Evox Therapeutics (EVOXW) Stock Price, News & Analysis

Company Overview

Evox Therapeutics plc is a biotechnology company developing therapeutics built on engineered extracellular vesicles (EVs), commonly referred to as exosomes, designed to deliver a broad range of therapeutic payloads. The company’s platform focuses on using naturally occurring nanoscale vesicles as vehicles to carry biologics—such as RNA, proteins and other macromolecules—into target cells and tissues. Evox aims to leverage the innate properties of EVs for targeted delivery, biodistribution and reduced immunogenicity compared with some synthetic delivery systems.

The company’s research and development activities center on engineering EVs for tissue-specific targeting and intracellular delivery, with the goal of addressing diseases that are difficult to treat with conventional approaches, including disorders of the central nervous system and certain rare genetic conditions. Evox pursues a pipeline of preclinical programs and research collaborations to progress potential therapeutic candidates, while also developing manufacturing and analytical capabilities intended to support scalable production of EV-based medicines.

Evox operates as a publicly traded company on the Nasdaq under the ticker EVOXW and engages with academic and industry partners to advance its science and translational efforts. The company describes its work as bridging advances in extracellular vesicle biology, molecular engineering and drug delivery to create new modalities for treating unmet medical needs. Evox’s corporate and scientific teams bring experience in biologics development, translational research and regulatory strategy to support the progression of its platform programs.

Key Stats

• Today's Range: $0.35 to $0.39
• 50-Day Range: $0.33 to $0.52
• 52-Week Range: $0.23 to $0.62
• Volume: 503 shs
• Average Volume: 34,810 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Capital Markets
• Sub-Industry: Asset Management & Custody Banks
• Current Symbol: NASDAQ:EVOXW
• CIK: 2077954
• Web: www.evoxtherapeutics.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A